EN
HI
Zydus Lifesciences share price chart
Zydus Lifesciences Share Key Metrics
Volume
6.66 L
Market Cap
112114.59 CR
LTQ@LTP
10@1114.20
ATP
1104.19
Var Margin
12.64 %
Circuit Range
1002.8-1225.6
Delivery %
65.83 %
Value
73.56 CR
ASM/GSM
No
Market Lot
1
Summary
ZYDUSLIFE stock price is ₹1114.2 as of 8 Aug, 2026. The stock intraday movement has stayed between ₹1093.20 and ₹1117.70, while Zydus Lifesciences share price 52 week high low is ₹835.50 & ₹1181.50.
In terms of trading activity, ZYDUSLIFE share price has recorded a volume of 6,66,151 shares. The Zydus Lifesciences has a market cap of ₹1006233990. The stock’s Average Traded Price (ATP) stands at ₹1104.19, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 10 @ ₹1114.20.
The Zydus Lifesciences upper circuit limit is ₹1225.60 & The Zydus Lifesciences lower circuit limit is ₹1002.80, with a Value of ₹73.56 CR. The Delivery Percentage for the day is 65.83%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Zydus Lifesciences Fundamentals
P/E Ratio
22.07
P/B Ratio
4.28
Div. Yield
0.09
Sector P/E
64.26
Sector P/B
3.26
Sec. Div. Yield
0.52
Zydus Lifesciences Resistance and Support
Pivot 1110.77
Resistance
First Resistance
1120.04
Second Resistance
1132.07
Third Resistance
1141.34
Support
First Support
1098.74
Second Support
1089.47
Third Support
1077.44
Zydus Lifesciences Futures & Options
Zydus Lifesciences Option Chain
View Price, OI, Greeks & More...
25AUG26
1122.90
15.20 (1.37%)
29SEP26
1122.40
9.30 (0.84%)
27OCT26
1132.00
11.00 (0.98%)
ZYDUSLIFE|25AUG26 CE 1110.00
34.15
3.5 (11.42%)
ZYDUSLIFE|25AUG26 PE 1120.00
31.35
-5.65 (-15.27%)
Zydus Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 07 2026 | 1102.1 | 1114.2 | 0.56% | 1117.7 | 1093.2 |
| Thu Aug 06 2026 | 1121 | 1108 | -1.17% | 1122.8 | 1101.5 |
| Wed Aug 05 2026 | 1130 | 1121.09 | -0.79% | 1130 | 1103.8 |
Zydus Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-11 | Quarterly Results |
| 2026-05-19 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Fund raising |
| 2025-08-12 | Quarterly Results |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-05 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
Zydus Lifesciences News
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Lifesciences received final approval from the USFDA for its Indocyanine Green for Injection. This approval grants 180-day Competitive Generic Therapy exclusivity in the US market, where the brand product's annual sales were approximately $125.8 million, indicating a significant market opportunity for the company.
Aug 04 2026 15:12:14
Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Zydus Life Science will participate in the Emkay Confluence 2026 investor conference on August 13, 2026. This participation is part of the company's ongoing investor relations efforts to engage with analysts and investors.
Aug 04 2026 13:13:12
Read More
Zydus Lifesciences Management
| Name | Position |
|---|---|
| Dhaval N Soni | Company Secretary & Compliance Officer |
| Pankaj R Patel | Chairman |
Zydus Lifesciences Similar Stocks
Divi's Laboratories Ltd.
8275.00
-74.00 (0.89%)
Torrent Pharmaceuticals Ltd.
4924.00
-32.00 (0.65%)
Apollo Hospitals Enterprise Ltd.
8945.00
-29.50 (0.33%)
Cipla Ltd.
1463.80
-13.20 (0.89%)
Lupin Ltd.
2363.50
-21.50 (0.90%)
Max Healthcare Institute Ltd.
1070.00
-2.40 (0.22%)
Mankind Pharma Ltd.
2456.00
35.70 (1.48%)
Laurus Labs Ltd.
1844.30
14.30 (0.78%)
Lenskart Solutions Ltd.
569.70
4.70 (0.83%)
Zydus Lifesciences FAQs
The Buying Price of Zydus Lifesciences share is 1114.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Zydus Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Zydus Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Zydus Lifesciences shares is 22.07. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Zydus Lifesciences shares is 4.28. Useful to assess the stock's value relative to its book value.
To assess Zydus Lifesciences’s valuation compare Sector P/E, P/B which are 64.26 & 3.26 with sector averages, along with growth rates and financial metrics.
The Market Cap of Zydus Lifesciences is 112114.59 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Zydus Lifesciences share price is 1181.50 & 835.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Zydus Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
